Spectra Logic Protects Critical Biomedical Research Data at Friedrich Miescher Institute for Biomedical Research (FMI)

Reading time for this article .
Subscribe to the Spectra Blog >

The Friedrich Miescher Institute for Biomedical Research, a part of the Novartis Research Foundation, Relies on Spectra T950 Tape Libraries for Scalable, High-Density Archiving

BOULDER, Colo.—March 9, 2010Spectra Logic, celebrating 30 years of data storage innovation, today announced that the Switzerland-based Friedrich Miescher Institute for Biomedical Research (FMI), a part of the Novartis Research Foundation, is relying on two Spectra® T950 tape libraries to archive and backup critical biomedical research data.
 
As a research institute, FMI exploits cutting edge research technology for biomedical research. FMI scientists are at the forefront of biomedical discovery, and are using high-throughput sequencing and microscopy experiments that can produce terabytes of data from a signal experiment. As a result, more than 10TB of new data is written to the Spectra Logic tape libraries each week in the form of new data or backups.
  
“Data volumes are doubling approximately every two years, so scalability is extremely important to us,” said Dean Flanders, chief information officer, FMI. “With Spectra Logic’s libraries we can easily scale by simply adding frames. We know our investment is protected and that our archiving and disaster recovery infrastructure will grow with us.” To accommodate its growing storage needs, FMI selected the Spectra T950 tape library to archive data automatically from disk-based primary storage. With the Spectra T950 solution, FMI can easily scale its storage capacity with the addition of up to seven additional frames, which would store more than 10PB of data.
  
After the initial implementation of the Spectra T950, FMI implemented a second T950 at a disaster recovery location. The second T950 stores an additional copy of the data from the initial T950 library. In the event of a significant incident or disaster affecting FMI’s primary data center, it is able to automatically shift from its normal disk staging to staging directly from tape at either site. The Spectra implementation has transformed FMI’s disaster recovery capabilities, enabling the IT team to bring terabytes of data back online in a matter of minutes.
 
“We are impressed and happy with the density and cost-effectiveness of the Spectra Logic offering,” added Flanders. “Innovation in tape is what Spectra Logic does extremely well, and we have grown very comfortable with entrusting our critical data to the Spectra Logic tape libraries.”
 
The full case study of the FMI implementation can be found at https://spectralogic.com/fmi.
 
# # #
About the Spectra T950
The Spectra T950 enterprise-class library is designed and built to meet the stringent requirements of the enterprise for data integrity, data security and high reliability. The T950 library simplifies management, reduces staff media handling time by 90 percent, scales in throughput and capacity, and supports multiple generations of tape and disk options. Support options range from the expected 24×7 worldwide onsite support as well as advanced options, such as the efficient Assisted Self Maintenance (ASM) option and proactive reporting and diagnostic tools for greater uptime.
 
About Spectra Logic Corporation
At Spectra Logic we define, design and deliver innovative data protection through tape, deduplication and disk-based backup, recovery and archive storage solutions.  By igniting innovation we challenge expectations of the data protection market with intelligent, integrated, and simple to use backup and archive technologies.  Throughout our 30-year history we have delivered high-density, feature rich storage with unmatched service and support to customers worldwide.  For more information, visit www.SpectraLogic.com.
 
About the FMI
The Friedrich Miescher Institute for Biomedical Research (FMI), based in Basel, Switzerland, is a world-class center for basic research in life sciences. It was founded in 1970 as a joint effort of two Basel-based pharmaceutical companies and is now part of the Novartis Research Foundation. The FMI is devoted to the pursuit of fundamental biomedical research. Areas of expertise are neurobiology, growth control, which includes signaling pathways, and the epigenetics of stem cell development and cell differentiation. The institute counts 320 collaborators. The FMI also offers training in biomedical research to PhD students and postdoctoral fellows from around the world. In addition the FMI is affiliated with the University of Basel. The Director of the FMI since 2004 is Prof. Susan Gasser.

Contacts:
Spectra Logic                                                              
Leigh Grace, 704-231-9789                                                           
leighg@spectralogic.com                                             
www.Twitter.com/spectralogic                                   
 
IGNITE Consulting
Kathleen Sullivan, 303-439-9365
Linda Dellett, 303-439-9398
 
Spectra and the Spectra Logic logo are registered trademarks of Spectra Logic Corporation. All rights reserved worldwide. All other trademarks and registered trademarks are the property of their respective owners.